Antimalarials and macrolides: review of off-label pharmacotherapies during the first wave of the sars-cov-2 pandemic

HIGHLIGHTS

• who: ABBREVIATIONS and colleagues from the Centro Ciu00eancias da Sau00fadeUniversidade Federal do AvenidaBrazil, Gonu00e7alo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil have published the article: Antimalarials and macrolides: review of off-label pharmacotherapies during the first wave of the SARS-CoV-2 pandemic, in the Journal: (JOURNAL) of June/05,/2020
• what: In this review, the authors critically analyzed the clinical trials carried out with CQ and HCQ with or without macrolides during the first wave of the COVID-19 pandemic, considering their design and limitations. In the United_States, a cohort multicenter study was designed . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.